Plasma rich in growth factors as treatment for a full-thickness macular hole due to macular telangiectasia type 2

Arch Soc Esp Oftalmol. 2021 Feb 21:S0365-6691(20)30491-3. doi: 10.1016/j.oftal.2020.11.021. Online ahead of print.ABSTRACTFull-thickness macular hole is a rare complication of macular telangiectasia type 2, and its treatment is still controversial. A patient with a full-thickness macular hole secondary to macular telangiectasia type 2 underwent vitreoretinal surgery with a plasma rich in growth factors membrane in the macular hole. At the sixth month of follow-up, anatomical and functional improvements were achieved, with no adverse effects. Plasma rich in growth factors is a new option, with advantages due to its biological properties that achieves good results in terms of safety and effectiveness in the surgical treatment of macular hole.PMID:33627242 | DOI:10.1016/j.oftal.2020.11.021

Source: Archivos de la Sociedad Espanola de Oftalmologia - February 25, 2021 Category: Opthalmology Authors: C M Rangel N A Blanco A Pedraza-Concha M A Gomez M M Parra J D Arias Source Type: research